. Author manuscript; available in PMC: 2016 Apr 2.

Published in final edited form as: Breast Cancer Res Treat. 2015 Apr 2;150(3):569–579. doi: 10.1007/s10549-015-3359-6

Table IIIA.

Phospho-p65 mean H-score statistics analyzed according to patient and tumor characteristics (Race, ER status, PR status, HER2 status).

		Number	Mean	Std Dev	Median	Minimum	Maximum	LSMean	P-value

Race	White	152	97.05	54.62	100	0	213.33	87.74	0.9992
	Black	154	67.66	58.42	65	0	255	87.53
	Other	1	90	---	90	90	90	85.83

ER	ER+	138	71.82	58.93	70	0	255	89.55	0.7153
ER	ER-	169	90.83	56.47	100	0	213.33	84.52	0.7153

PR	PR+	128	70.69	59.14	113.33	0	223.33	78.83	0.2381
PR	PR-	179	90.58	56.35	96.67	0	213.33	95.25	0.2381

HER2	HER2+	93	84.24	58.26	90	0	255	95.04	0.0322
HER2	HER2-	214	81.44	58.37	82.5	0	216.67	79.03	0.0322

Stage	0	1	115	---	115	115	115	76.99	0.0038
	1	77	108.53	60.11	110	0	255	98.17
	2	143	73.31	55.45	73.33	0	203.33	72.79
	3	74	68.18	51.46	70	0	190	66.08
	4	5	121.33	83.15	160	16.67	216.67	121.16